10 ¹ú¼ÊÃ×À¼¶ÔÕó¿ÆÄª AI spinouts
02 April 2025Meet 10 ¹ú¼ÊÃ×À¼¶ÔÕó¿ÆÄª spinouts, all hoping to harness the potential of AI for the good of the planet and its people.
Meet 10 ¹ú¼ÊÃ×À¼¶ÔÕó¿ÆÄª spinouts, all hoping to harness the potential of AI for the good of the planet and its people.
Kathryn Chapman, Executive Director of Innovate ¹ú¼ÊÃ×À¼¶ÔÕó¿ÆÄª, on the secrets of successful innovation and her ambitious plans for innovation in ¹ú¼ÊÃ×À¼¶ÔÕó¿ÆÄª and beyond.Ìý
A team from across the ¹ú¼ÊÃ×À¼¶ÔÕó¿ÆÄª life sciences, technology and business worlds has announced a multi-million-pound, three-year collaboration with the Advanced Research and Invention Agency (ARIA), the UK government’s new research funding agency.
¹ú¼ÊÃ×À¼¶ÔÕó¿ÆÄª scientists have grown ‘mini-guts’ in the lab to help understand Crohn’s disease, showing that ‘switches’ that modify DNA in gut cells play an important role in the disease and how it presents in patients.
The facility, based at the Milner Therapeutics Institute, will support the discovery of new medicines and diagnostics for chronic diseases by applying advanced biological and technological tools, including CRISPR gene editing.
Connect: Health Tech, the ¹ú¼ÊÃ×À¼¶ÔÕó¿ÆÄª Enterprise Zone, has today launched a roadmap, ‘Creating a University Enterprise Zone for ¹ú¼ÊÃ×À¼¶ÔÕó¿ÆÄª across the life and physical sciences’, that examines the challenges faced in futureproofing and sustaining the growth of the life sciences cluster to maintain ¹ú¼ÊÃ×À¼¶ÔÕó¿ÆÄª as a global centre of excellence for health tech.
¹ú¼ÊÃ×À¼¶ÔÕó¿ÆÄª scientists have identified 200 approved drugs predicted to work against COVID-19 – of which only 40 are currently being tested in COVID-19 clinical trials.
Three companies,ÌýAstex Pharmaceuticals,ÌýEisai LtdÌýandÌýEli Lilly and Company, are joining forces with research scientists across ¹ú¼ÊÃ×À¼¶ÔÕó¿ÆÄª to explore promising new approaches to the treatment of neurodegenerative disease.
Scientists have made a promising step towards developing a new drug for treating acute myeloid leukaemia, a rare blood disorder. In a study published today in Nature, ¹ú¼ÊÃ×À¼¶ÔÕó¿ÆÄª researchers report a new approach to cancer treatment that targets enzymes which play a key role in translating DNA into proteins and which could lead to a new class of cancer drugs.
A new collaboration between the ¹ú¼ÊÃ×À¼¶ÔÕó¿ÆÄª, Papworth Hospital NHS Foundation Trust and Sunway Medical Centre in Malaysia will see researchers and clinicians from the two countries working together across borders and disciplinary divides to tackle some of the world’s major health challenges.
Ìý